ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2521 - 2535 of 5996 products
Panacea Venture Raises $180.5 Million to Back Early Stage Healthcare Companies
$5.00
Available
New Horizon Health Closes $66 Million C Round for Diagnostics
$5.00
Available
Shanghai Allist Pharma Completes $174 Million A Round
$5.00
Available
Joinn Labs to Acquire US-Based Biomere, a Pre-clinical CRO, for $27.3 Million
$5.00
Available
CStone's In-Licensed Cancer Treatment Meets Endpoints in Phase III Trial
$5.00
Available
WuXi Biologics Signs LOI for $3 Billion Vaccine Manufacturing Contract
$5.00
Available
Xynomic Presents Positive Long-Term Data on Lead Oncology Candidate
$5.00
Available
Exuma Reports Positive Early Results from China Trial of Conditionally Active Biologics
$5.00
Available
Sandoz Approved to Launch Crestor, a Generic Statin, in China
$5.00
Available
Hangzhou's AnHeart Completes $14.6 Million A Funding from Decheng
$5.00
Available
ChemPartner Adds B Cell Discovery to Berkeley Lights Collaboration
$5.00
Available
Leads Biolabs Grants License for Inhaled Delivery of Immunotherapies
$5.00
Available
WuXi Biologics Starts Building Chengdu Manufacturing Plant, its 12th Globally
$5.00
Available
Xynomic Closes $191.6 Million Merger with Bison Capital; Now Listed on Nasdaq Exchange
$5.00
Available
Winhealth to Market Two Cumberland Pharma Pain Drugs in China
$5.00
Available